Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Note Mattifying Extreme Wear Foundation 03 Medium Beige OCTINOXATE 6 mg/mL Cream — NDC 70474-002-01 (Billing 70474-0002-01)
by ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI · 1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE
This is a package of Note Mattifying Extreme Wear Foundation 03 Medium Beige OCTINOXATE 6 mg/mL Cream from ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI, marketed since Jan 2023 and currently FDA-listed. It is this product's only package size.
NDC 70474-0002-01
🏷️ FDA NDC (as labeled)
70474-002-01
billing pads the product segment with a zero
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
70474-002-01
Product NDC
70474-002
11-digit billing NDC
70474000201
UNII
4Y5P7MUD51
UPC
3701365780695
Application #
M020
SPL Set ID
feac1cc2-eb4c-43da-89fc-6c950202b00d
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2023-01-29
Route
TOPICAL
Dosage form
CREAM
Substance
OCTINOXATE
Why two NDCs?
The FDA registers this code as 70474-002-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 70474-0002-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
🧪 What is this product?
This is a topical cream foundation that functions as an over-the-counter sunscreen product. The active ingredient octinoxate is a UV filter commonly used in sunscreen and cosmetic products to help absorb ultraviolet light and reduce sun exposure to the skin. As an OTC monograph drug, this product is marketed under established FDA guidelines for sunscreen ingredients rather than as an individually approved application. The cream is designed to be applied to the face as part of a cosmetic foundation routine.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
💬 Questions about OCTINOXATE?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 2, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 70474-0002-01 You're viewing this Main listing | 1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE | 2023-01-29 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Note Mattifying Extreme Wear Foundation 113 Honey Bronze 6 mg/mL 70474-0009-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation, 100 Cashmere Beige 6 mg/mL 70474-0006-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 108 Terra 6 mg/mL 70474-0007-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 125 Ivory Beige 6 mg/mL 70474-0013-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note BB Concealer 01 6 mg/mL 70474-0015-01 | ALTONA | 1 tube | — | — | FDA listed | — |
| Note BB Advanced Skin Corrector SPF 15, 01 6 mg/mL 70474-0019-01 | ALTONA | 1 tube | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 03 Medium Beige 6 mg/mLthis 70474-0002-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 07 Apricot 6 mg/mL 70474-0004-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 110 Smoke 6 mg/mL 70474-0008-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 114 Latte 6 mg/mL 70474-0010-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note BB Concealer 03 6 mg/mL 70474-0017-01 | ALTONA | 1 tube | — | — | FDA listed | — |
| Note BB Advanced Skin Corrector SPF 15, 02 6 mg/mL 70474-0020-01 | ALTONA | 1 tube | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 04 Sand 6 mg/mL 70474-0003-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 08 Sunny 6 mg/mL 70474-0005-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note BB 200 Soft Ivory 6 mg/mL 70474-0022-01 | ALTONA | 1 tube | — | — | FDA listed | — |
| Note BB 300 Light Beige 6 mg/mL 70474-0023-01 | ALTONA | 1 tube | — | — | FDA listed | — |
| Note BB 500 6 mg/mL 70474-0024-01 | ALTONA | 1 tube | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 02 Natural Beige 6 mg/mL 70474-0001-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note BB Concealer 02 6 mg/mL 70474-0016-01 | ALTONA | 1 tube | — | — | FDA listed | — |
| Note BB 100 Porcelain 6 mg/mL 70474-0021-01 | ALTONA | 1 tube | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 116 Golden Beige 6 mg/mL 70474-0012-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note Sunglow Foundation 6 mg/mL 70474-0018-01 | ALTONA | 1 tube | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 6 mg/mL 70474-0000-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 115 Ebony 6 mg/mL 70474-0011-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
| Note Mattifying Extreme Wear Foundation 130 Cool Rose 6 mg/mL 70474-0014-01 | ALTONA | 1 bottle | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2023
On the market since
Jan 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Sep 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 3K9958V90M
A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
-
UNII I9PJ0O6294
A modified starch derived from corn or potato starch with aluminum salt and octenylsuccinic acid added. It acts as a binder to hold tablet ingredients together and as a thickening agent in liquid formulations.
-
UNII 1P9D0Z171K
BHT is a synthetic antioxidant that prevents fats and oils in medicines from breaking down and becoming rancid. It helps keep the product stable and effective during storage.
-
UNII 3XUS85K0RA
Butylene glycol is a clear liquid derived from petroleum or plants that acts as a humectant, solvent, and preservative booster in medicines. It helps keep formulations stable, dissolve active ingredients, and maintain moisture in topical products.
-
UNII JEX140NPX8
A natural essential oil derived from Cedrus atlantica wood, used as a fragrance ingredient and preservative to add pleasant scent and help maintain product stability.
-
UNII 0THT5PCI0R
A silicone-based liquid that helps distribute active ingredients evenly throughout topical products. It acts as a solvent and emollient, allowing medicines to spread smoothly on skin while improving texture and absorption.
-
UNII 92RU3N3Y1O
Dimethicone is a silicone-based oil that acts as an anti-foaming agent and lubricant in medicines. It reduces gas bubbles in liquid formulations and helps coat and protect the stomach lining when ingested.
-
UNII X687XDK09L
A clay mineral processed to carry positive charges, used as a thickener and suspending agent in liquid medicines. It helps keep solid particles evenly distributed throughout the product.
-
UNII 147D247K3P
Ethylhexylglycerin is a synthetic preservative used to prevent bacteria and mold from growing in medicines and personal care products. It helps keep the product safe and stable throughout its shelf life.
-
UNII 997724QNDS
A plant extract from meadowsweet root used as a flavoring agent or natural ingredient to add taste and aroma to medicines.
-
UNII WB5K9Y35Y9
A synthetic crosslinked polymer made by combining hexamethylene diisocyanate with trimethylol hexyllactone. It's used as a film-former and binder to help create protective coatings on tablets or capsules and improve product stability.
-
UNII HIE492ZZ3T
Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
-
UNII 6DC9Q167V3
Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII 451W47IQ8X
Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
-
UNII LDC331P08E
A silicone-based compound that acts as a glidant and flow agent in solid medications. It reduces friction between powder particles, helping the medicine flow smoothly during manufacturing and tablet compression.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
17 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesCyclopentasiloxane, Water (Aqua), PEG-10 Dimethicone, Butylene Glycol, Dimethicone, HDI/Trimethylol Hexyllactone Crosspolymer, Disteardimonium Hectorite, Aluminum Starch Octenylsuccinate, Phenoxyethanol, Alcohol, Triethoxycaprylylsilane, Propylene Glycol, Trimethylsiloxysilicate, Sodium Chloride, Dimethicone/Vinyl Dimethicone Crosspolymer, Cedrus (Cedrus atlantica) Wood Oil, Fragrance (Parfum), Ethylhexylglycerin, Silica, BHT, Meadowsweet (Spiraea ulmaria) Extract, May contain: Titanium Dioxide (CI 77891), Iron Oxides (CI 77491, CI 77492, CI 77499)
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI
FDA applicationM020 (OTC MONOGRAPH DRUG)
Labeler code70474
First marketedJan 2023
Product typeHuman Otc Drug
Portfolio25 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Do Not Use
📄 When Using This Product
📄 Stop Use and Ask a Doctor If
📄 Keep Out of Reach of Children
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses Helps prevent sunburn. if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
⏱️ Dosage and Administration ▾
Directions Apply liberally 15 minutes before sun exposure Reapply at least every 2 hours Use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m.-2 p.m. wear long-sleeved shirts, pants, hats, and sunglasses children under 6 months of age: ask a doctor
⚠️ Warnings ▾
Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active ingredient Octinoxate 0.6% Purpose Sunscreen
🧪 Inactive Ingredients ▾
Inactive ingredients Cyclopentasiloxane, Water (Aqua), PEG-10 Dimethicone, Butylene Glycol, Dimethicone, HDI/Trimethylol Hexyllactone Crosspolymer, Disteardimonium Hectorite, Aluminum Starch Octenylsuccinate, Phenoxyethanol, Alcohol, Triethoxycaprylylsilane, Propylene Glycol, Trimethylsiloxysilicate, Sodium Chloride, Dimethicone/Vinyl Dimethicone Crosspolymer, Cedrus (Cedrus atlantica) Wood Oil, Fragrance (Parfum), Ethylhexylglycerin, Silica, BHT, Meadowsweet (Spiraea ulmaria) Extract, May contain: Titanium Dioxide (CI 77891), Iron Oxides (CI 77491, CI 77492, CI 77499)
🎯 Purpose ▾
Purpose Sunscreen
📄 Do Not Use ▾
Do not use on damaged or broken skin
📄 When Using This Product ▾
When using this product keep out of eyes. Rinse with water to remove.
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if rash occurs
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📄 Package Label / Principal Display Panel ▾
Package Labeling: Outer Label Inner Label
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Note Mattifying Extreme Wear Foundation 03 Medium Beige (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 29%
Female · 71%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.